Follow-The-Filings

Security · featured owners

KTTA Pasithea Therapeutics Corp.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $1M
  • 1 new

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman new 0.10%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 0.10% New 0.10% 2,050,000 $1M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 20 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07,9.01 Filing Doc
8-K 3.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-K ANNUAL REPORT Filing Doc
8-K 3.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
424B4 PROSPECTUS Filing Doc
S-1/A AMENDMENT NO. 1 TO FORM S-1 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
S-1 REGISTRATION STATEMENT Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Jun 17, 2026 Filing Doc
4 Period May 1, 2026 · 7 forms Filing Doc
4 Period Nov 28, 2025 · 5 forms Filing Doc
4 Period Oct 24, 2025 · 6 forms Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$15.96M -$13.9M -$20.43M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.69M $7.37M $56.46M
Total non-current assets * $9.42M $8.7M $3.78M
Total assets $26.12M $16.06M $60.24M
Total current liabilities $2.63M $1.12M $4.97M
Total non-current liabilities $84,366 $162,172 $46,871
Total equity $23.4M $14.78M $55.22M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations — — -$15.21M
Cash from investing — — $11,000
Cash from financing — — $63.52M
Net change in cash -$16.76M -$9.41M $48.34M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders

Q2 2026

period archive